How the side effects of naltrexone and GLP-1 compare
In a Phase 2a trial focused on metabolic dysfunction-associated steatotic liver disease (MASLD, formerly called NAFLD), retatrutide delivered the following liver fat reductions: Read those numbers again
This allows testosterone levels to stabilize and energy improvements to manifest before appetite suppression kicks in
Understanding this connection can help you take steps to manage this side effect while continuing your treatment
Well tailor the schedule based on your symptoms, diet, age, and any medications youre on
This triple-agonist approach enables researchers to study the combined effects of appetite regulation, insulin secretion, and energy expenditure in a single molecule, making it uniquely valuable for obesity models, metabolic syndrome research, and studies exploring synergistic receptor interactions beyond what dual agonists can achieve